15:42

The Clinical Impact of Bioprosthetic Valve Performance After Surgery and TAVR
13:59

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team
16:16

Long-term Outcomes After TAVR
12:49

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve
42:51

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial
Subscribe to TAVR